Marta Białek

ORCID: 0000-0002-0928-9993
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Linguistics, Language Diversity, and Identity
  • COVID-19 and Mental Health
  • Bacillus and Francisella bacterial research
  • 3D Printing in Biomedical Research
  • Long-Term Effects of COVID-19
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Polyomavirus and related diseases
  • Names, Identity, and Discrimination Research
  • Cell Image Analysis Techniques
  • Peripheral Neuropathies and Disorders
  • Language and Culture

Warsaw University of Technology
2024

Wojewódzki Szpital Specjalistyczny nr 4 w Bytomiu
2021-2022

Ateneum University
2020

Introduction. The aim of this study was to report the course and outcome SARS-CoV-2 infection in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs) Poland. A major concern for neurologists worldwide is MS different DMTs. Although initial studies do not suggest an unfavourable group patients, data limited. Materials methods. This included 396 DMTs confirmed from 28 Polish centres. Information concerning patient demographics, comorbidities, clinical MS, current...

10.5603/pjnns.a2021.0031 article EN other-oa Neurologia i Neurochirurgia Polska 2021-04-15

(1) Background: The present study aims to report the side effects of vaccination against coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) who were being treated disease-modifying therapies (DMTs) in Poland. (2) Methods: included 2261 MS DMTs, and vaccinated COVID-19 16 Polish centers. data collected demographic information, specific characteristics, current type vaccine, after vaccination, time side-effect symptom onset resolution, applied treatment, relapse...

10.3390/vaccines10050763 article EN cc-by Vaccines 2022-05-12

(1) Background: To report and analyze the presence of residual symptoms after SARS-CoV-2 infection among Polish patients with multiple sclerosis (MS) treated different disease-modifying therapies (DMTs). (2) Methods: The study included 426 individuals MS DMTs confirmed from 12 centers. data were collected through to 31 May 2021. information demographics, specific characteristics, course infection, (general neurological) lasting more than four weeks initial infection. results obtained using...

10.3390/jcm10225225 article EN Journal of Clinical Medicine 2021-11-10

Since vaccination against COVID-19 is available for over a year and the population of immunized individuals with autoimmune disorders higher than several months before, an evaluation safety registered adverse events can be made. We conducted large study side effects following vaccine among patients multiple (MS) sclerosis treated disease-modifying therapies (DMTs) analyzed factors predisposing particular events.We gathered data MS DMTs from 19 Polish Centers, who reported at least one event...

10.3389/fneur.2022.913283 article EN cc-by Frontiers in Neurology 2022-06-14

Translating culture-specific elements proves to be a challenging task, obliging the translator refer his/her extratextual knowledge. Such necessity is especially noticeable in case of onomastics which constitutes vital part Olga Tokarczuk’s novel Primeval and Other Times. Its English translator, Antonia Lloyd-Jones, decided adopt only few translation strategies for proper nouns specified by Andrew Chesterman, most instances bereft source text its complexity.

10.36575/2353-2912/1(8)2020.299 article EN cc-by-sa Forum Filologiczne Ateneum 2020-11-01
Coming Soon ...